These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37387488)

  • 1. Evaluation of Vancomycin Area Under the Concentration-Time Curve Predictive Performance Using Bayesian Modeling Software With and Without Peak Concentration: An Academic Hospital Experience for Adult Patients Without Renal Impairment.
    Kim HK; Jeong TD
    Ann Lab Med; 2023 Nov; 43(6):554-564. PubMed ID: 37387488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conversion from Vancomycin Trough Concentration-Guided Dosing to Area Under the Curve-Guided Dosing Using Two Sample Measurements in Adults: Implementation at an Academic Medical Center.
    Meng L; Wong T; Huang S; Mui E; Nguyen V; Espinosa G; Desai J; Holubar M; Deresinski S
    Pharmacotherapy; 2019 Apr; 39(4):433-442. PubMed ID: 30739349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of Acute Kidney Injury Based on Vancomycin Target Trough Attainment Strategy: Area-Under-the-Curve-Guided Bayesian Software, Nomogram, or Trough-Guided Dosing.
    Knight JM; Iso T; Perez KK; Swan JT; Janak CE; Ikwuagwu JO; Musick WL
    Ann Pharmacother; 2024 Feb; 58(2):110-117. PubMed ID: 37144736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical assessment of the revised guidelines for vancomycin therapeutic drug monitoring.
    Aljutayli A; Thirion DJG; Nekka F
    Biomed Pharmacother; 2022 Nov; 155():113777. PubMed ID: 36271558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical validation of the two-point method for predicting vancomycin AUC based on peak and trough plasma concentrations.
    Wang L; Lin X; Wang L; Ye H; Lin Y; Ruan J; Shi S
    Int J Clin Pharm; 2022 Dec; 44(6):1325-1331. PubMed ID: 36136207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Predictive performance of population pharmacokinetic software on vancomycin steady-state trough concentration].
    Xue S; Lu H; Tang L; Fang J; Shi L; Li J; Yu Y; Zhou Q; Xue S
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Jan; 32(1):50-55. PubMed ID: 32148231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective Trial on the Use of Trough Concentration versus Area under the Curve To Determine Therapeutic Vancomycin Dosing.
    Neely MN; Kato L; Youn G; Kraler L; Bayard D; van Guilder M; Schumitzky A; Yamada W; Jones B; Minejima E
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Evaluation of a Novel Software Program, SAKURA-TDM, for Area Under the Concentration-Time Curve-Guided Vancomycin Dosing: A Short Communication.
    Horita Y; Asaoka M; Iida M; Kato H; Wachino C; Mitamura K; Ohashi K; Mimura Y; Hotta Y; Kataoka T; Nakamura A; Kimura K
    Ther Drug Monit; 2023 Apr; 45(2):245-250. PubMed ID: 36006610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should the trough concentration of vancomycin be abandoned in therapeutic drug monitoring? A multicentre, retrospective study of critically ill patients without any form of dialysis.
    Yu Z; Liu J; Yu H; Zhou L; Zhao Y; Zhong L; Zhu J; Liang G; Yang Y; Zheng Y; Yu L; Han G
    Int J Antimicrob Agents; 2023 Jun; 61(6):106812. PubMed ID: 37037321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic equations versus Bayesian guided vancomycin monitoring: Pharmacokinetic model and model-informed precision dosing trial simulations.
    Aljutayli A; Thirion DJG; Bonnefois G; Nekka F
    Clin Transl Sci; 2022 Apr; 15(4):942-953. PubMed ID: 35170243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vancomycin area under the curves estimated with pharmacokinetic equations using trough-only data.
    Fewel N
    J Clin Pharm Ther; 2021 Oct; 46(5):1426-1432. PubMed ID: 34169543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of Bayesian Area Under the Concentration-Time Curve-Based Pharmacokinetic Dosing Based on a One-Compartment Model and Trough-Only Monitoring for Vancomycin.
    Salehpour N; Riley LD; Gonzales MJ; Kobic E; Nix DE
    Antimicrob Agents Chemother; 2023 Jun; 67(6):e0017223. PubMed ID: 37133362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vancomycin therapeutic monitoring by measured trough concentration versus Bayesian-derived area under the curve in critically ill patients with cancer.
    AbuSara AK; Abdelrahman DH; Habash KI; Al-Shaer MH; Le J; Nazer LH
    Pharmacol Res Perspect; 2022 Feb; 10(1):e00912. PubMed ID: 34990089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-benefit analysis comparing trough, two-level AUC and Bayesian AUC dosing for vancomycin.
    Lee BV; Fong G; Bolaris M; Neely M; Minejima E; Kang A; Lee G; Gong CL
    Clin Microbiol Infect; 2021 Sep; 27(9):1346.e1-1346.e7. PubMed ID: 33221430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flowchart for predicting achieving the target area under the concentration-time curve of vancomycin in critically ill Japanese patients: A multicenter retrospective study.
    Ishigo T; Fujii S; Ibe Y; Aigami T; Nakano K; Fukudo M; Yoshida H; Tanaka H; Ebihara F; Maruyama T; Hamada Y; Suzuki A; Fujihara H; Yamaguchi F; Samura M; Nagumo F; Komatsu T; Tomizawa A; Takuma A; Chiba H; Nishi Y; Enoki Y; Taguchi K; Matsumoto K
    J Infect Chemother; 2024 Apr; 30(4):329-336. PubMed ID: 37925103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of renal clearance on vancomycin area under the concentration-time curve deviations in critically ill patients.
    Ishigo T; Ibe Y; Fujii S; Kazuma S; Aigami T; Kashiwagi Y; Takada R; Takahashi S; Fukudo M; Toda T
    J Infect Chemother; 2023 Aug; 29(8):769-777. PubMed ID: 37150254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced nephrotoxicity with vancomycin therapeutic drug monitoring guided by area under the concentration-time curve against a trough 15-20 μg/mL concentration.
    Oda K; Jono H; Nosaka K; Saito H
    Int J Antimicrob Agents; 2020 Oct; 56(4):106109. PubMed ID: 32721597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review and Validation of Bayesian Dose-Optimizing Software and Equations for Calculation of the Vancomycin Area Under the Curve in Critically Ill Patients.
    Turner RB; Kojiro K; Shephard EA; Won R; Chang E; Chan D; Elbarbry F
    Pharmacotherapy; 2018 Dec; 38(12):1174-1183. PubMed ID: 30362592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of vancomycin area under the curve calculated based on Bayesian approach versus equation-based approach.
    Lee E; Yu U; Park JI; Park SI
    Int J Clin Pharmacol Ther; 2024 May; 62(5):204-212. PubMed ID: 38329916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of Area under the Concentration-Time Curve Estimations of Vancomycin with Limited Sampling by a Newly Developed Web Application.
    Oda K; Hashiguchi Y; Kimura T; Tsuji Y; Shoji K; Takahashi Y; Matsumoto K; Kawamura H; Saito H; Takesue Y
    Pharm Res; 2021 Apr; 38(4):637-646. PubMed ID: 33782837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.